154 related articles for article (PubMed ID: 22898831)
1. Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination.
Jin HJ; Sui HX; Wang YN; Gao FG
J Clin Immunol; 2013 Jan; 33(1):246-54. PubMed ID: 22898831
[TBL] [Abstract][Full Text] [Related]
2. Nicotine stimulated bone marrow-derived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway.
Jin HJ; Li HT; Sui HX; Xue MQ; Wang YN; Wang JX; Gao FG
Immunol Lett; 2012 Aug; 146(1-2):40-9. PubMed ID: 22546501
[TBL] [Abstract][Full Text] [Related]
3. Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer.
Gao FG; Li HT; Li ZJ; Gu JR
J Clin Immunol; 2011 Feb; 31(1):80-8. PubMed ID: 20957418
[TBL] [Abstract][Full Text] [Related]
4. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo nicotine stimulation augments the efficacy of therapeutic bone marrow-derived dendritic cell vaccination.
Gao FG; Wan da F; Gu JR
Clin Cancer Res; 2007 Jun; 13(12):3706-12. PubMed ID: 17575236
[TBL] [Abstract][Full Text] [Related]
6. Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.
Weng X; Kuang Y; Liu X; Chen Z; Zhu H; Chen H; Jiang B; Shen H
Braz J Med Biol Res; 2011 Mar; 44(3):186-92. PubMed ID: 21243315
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
9. CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects.
Park HM; Sohn HJ; Kim YJ; Cho HI; Kim TG
Vaccine; 2014 Dec; 32(51):6919-6926. PubMed ID: 25444817
[TBL] [Abstract][Full Text] [Related]
10. The change of immunoactivity of dendritic cells induced by mouse 4-1BBL recombinant adenovirus.
Youlin K; Xiaodong W; Xiuheng L; Zhiyuan C; Hengcheng Z; Hui C; Botao J
Yonsei Med J; 2010 Jul; 51(4):594-8. PubMed ID: 20499429
[TBL] [Abstract][Full Text] [Related]
11. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide and dose of nicotine determine the effects of nicotine on murine bone marrow-derived dendritic cells.
Hu SX; Sui HX; Jin HJ; Ni XY; Liu XX; Xue MQ; Zhang Y; Gao FG
Mol Med Rep; 2012 Apr; 5(4):1005-10. PubMed ID: 22245993
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway.
Wang YY; Yang YW; You X; Deng XQ; Hu CF; Zhu C; Wang JY; Gu JJ; Wang YN; Li Q; Gao FG
Anal Cell Pathol (Amst); 2015; 2015():741487. PubMed ID: 26351626
[TBL] [Abstract][Full Text] [Related]
14. K33 only mutant ubiquitin augments bone marrow-derived dendritic cell-mediated CTL priming via PI3K-Akt pathway.
Liang YY; Liao XY; Jia JJ; Yin YZ; Zhang YH; Gao FG
Immunology; 2024 Jul; 172(3):486-499. PubMed ID: 38547355
[TBL] [Abstract][Full Text] [Related]
15. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide preferentially induces 4-1BB ligand expression on human monocyte-derived dendritic cells.
Lee PK; Chang CJ; Lin CM
Immunol Lett; 2003 Dec; 90(2-3):215-21. PubMed ID: 14687728
[TBL] [Abstract][Full Text] [Related]
17. Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.
Wang R; Freywald A; Chen Y; Xu J; Tan X; Xiang J
Cell Mol Immunol; 2015 Jul; 12(4):456-65. PubMed ID: 25195511
[TBL] [Abstract][Full Text] [Related]
18. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.
Sharma RK; Schabowsky RH; Srivastava AK; Elpek KG; Madireddi S; Zhao H; Zhong Z; Miller RW; Macleod KJ; Yolcu ES; Shirwan H
Cancer Res; 2010 May; 70(10):3945-54. PubMed ID: 20406989
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
